Biosimilar: An alternative to reduce treatment costs as demand for chronic disease management rises

Retrieved on: 2022-12-18 15:22:46

Tags for this article:

Click the tags to see associated articles and topics

Biosimilar: An alternative to reduce treatment costs as demand for chronic disease management rises. View article details on hiswai:

Excerpt

However, other than sustainable steps, some biopharmaceutical companies ... requirements need to be efficiently handled by Biopharma companies, ...

Article found on: www.financialexpress.com